Keywords: Diagnosis/Prediction, Machine Learning/Artificial Intelligence, Astrocytoma, Glioblastoma, Magnetic resonance imaging, Molecular subtype.
Motivation: Accurately predict the molecular subtypes of 2021 WHO grade 4 glioma
Goal(s): To develop and validate a machine learning (ML) model using multiparametric MRI for the preoperative differentiation of grade 4 astrocytoma and glioblastoma (GBM) (Task 1), and to stratify grade 4 astrocytoma to distinguish isocitrate dehydrogenase-mutant (IDH-mut) from IDH-wild-type (IDH-wt) (Task 2). Additionally, to evaluate the model’s prognostic value
Approach: retrospectively study
Results: The combined model and the optimal ML model significantly outperformed the clinical model in both the training and validation sets. Survival analysis showed the combined model performed similarly to molecular subtype in both tasks.
Impact: l The multiparametric MRI machine learining model can accurately predict molecular subtypes of 2021 WHO grade 4 glioma, offers substantial prognostic value and provides a new perspective for clinical decision-making.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords